Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
| 3p21 | * Muscular dystrophy-dystroglycanopathy (limb-girdle) - MDDGC9 (1.53, 2.26) * Congenital muscular dystrophy with hypoglycosylation of dystroglycan type A9 - MDDGA9 (1.53, 2.26)
|
DCAF8DDB1 and CUL4 associated factor 8 | 1q23.2 | * Giant axonal neuropathy 2 - GAN2 (14.133)
|
| 2p13 | * Neuronopathy, distal hereditary motor, autosomal dominant 14 - HMND14 (12.37, 12.80) * Susceptibility to amyotrophic lateral sclerosis related to dynactin 1 - (12.37, 12.80)
|
DDHD1DDHD domain containing 1 | 14q21 | * Spastic paraplegia 20 - SPG28 (15.41)
|
DDHD2DDHD domain containing protein 2 | 8p11.23 | * Spastic paraplegia 54, autosomal recessive - SPG54 (15.57)
|
| 2q35 | * Desmin-related myopathy - DRM (5.1, 5.15, 10.135, 10.47, 11.44) * Limb-Girdle, Muscular dystrophy, type 2R - LGMD2R (5.1, 5.15, 5.15, 10.135, 10.47, 11.44) * Dilated cardiomyopathy, 1I - CMD1I (5.1, 5.1, 5.15, 5.15, 10.135, 10.47, 11.44) * Arrhythmogenic right ventricular dysplasia with myofibrillar myopathy - ARVD7 (5.1, 5.1, 5.15, 5.15, 10.135, 10.47, 11.44) * Myofibrillar myopathy 1 - MFM1 (5.1, 5.1, 5.15, 5.15, 10.135, 10.47, 11.44) * Myopathy, cardiomyopathy and congenital myasthenic syndrome - (5.1, 5.1, 5.15, 5.15, 10.135, 10.47, 11.44) * Limb girdle muscular dystrophy 1E (autosomal dominant) - LGMD1E (5.1, 5.1, 5.15, 5.15, 10.135, 10.47, 11.44)
|
DGAT2Diacylglycerol O-acyltransferase 2 | 1q13.3 | * Early onset axonal neuropathy with sensory ataxia - (14.81)
|
DGUOKDeoxyguanosine kinase(M) | 2p13.1 | * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 4 - PEOB4 (16.43, 16.47) * Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) - MTDPS3 (16.43, 16.47)
|
DHTKD1Dehydrogenase E1 and transketolase domain containing 1(M) | 10p14 | * Charcot-Marie-Tooth neuropathy Type 2Q - CMT2Q (14.69)
|
| 1q25.3 | * Charcot-Marie-Tooth disease, axonal, related to DHX9 - CMT2 (14.86)
|
| Xp21.2 | * Duchenne muscular dystrophy - DMD (1.1, 10.92) * Becker muscular distrophy - BMD (1.1, 10.92) * Cardiomyopathy, Dilated, 3B - CMD3B (1.1, 10.92) * Cardiomyopathy, dilated, X-linked - XLCM (1.1, 10.92)
|
DMPKMyotonic dystrophy protein kinase | 19q13.3 | * Myotonic dystrophy 1 - DM1 (6.1) * Dystrophia myotonica - DM (6.1) * Steinert disease - DM1 (6.1)
|
DNA2DNA replication helicase 2(M) | 10q21.3 | * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 - PEOA6 (16.39)
|
DNAJB2DnaJ (Hsp40) homolog, subfamily B, member 2 | 2q32-q34 | * Spinal muscular atrophy, distal related to DNAJB2 - (12.17, 14.91) * Spinal muscular atrophy, distal, autosomal recessive, 5 - DSMA5 (12.17, 14.91) * Autosomal recessive CMT2 related to DNAJB2 - (12.17, 14.91)
|
DNAJB4DNAJ/HSP40 homolog, subfamily B, member 4 | 1p31.1 | * Myopathy with early respiratory failure - (5.16)
|
DNAJB6HSP-40 homologue, subfamily B, number 6 | 7q36 | * LGMDD1 - (1.16, 4.24, 4.25)
|
| 19p13.2 | * Charcot-Marie-Tooth disease, dominant intermediate B - CMTDIB (2.15, 3.19, 4.20, 12.91, 14.16) * Myopathy centronuclear, 1 - CNM1 (2.15, 3.19, 4.20, 12.91, 14.16) * Lethal Congenital Contracture Syndrome 5 - LCCS5 (2.15, 3.19, 4.20, 12.91, 14.16)
|
DNMT1DNA (cytosine-5)-methyltransferase 1 | 19p13.2 | * Neuropathy, hereditary sensory, type 1E - HSN1E (14.119) * Hereditary sensory neuropathy with dementia and hearing loss - (14.119)
|
| 4p16.2 | * Familial limb-girdle myasthenia related to DOK7 - CMS1B (11.18, 16.28) * Fetal akinesia deformation sequence 3 - FADS3 (11.18, 16.28) * Myasthenic syndrome, congenital, 10 - CMS10 (11.18, 16.28)
|
| 9q34.13 | * Dilated Cardiomyopathy related to DOLK - CDG1M (10.95)
|
DPAGT1Dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) | 11q23.3 | * Familial imb-girdle myasthenia with tubular aggregates related to DPAGT1 - CMSTA2 (11.21) * Myasthenic syndrome, congenital, 13, with tubular aggregates - CMS13 (11.21)
|
DPM1Dolichyl-phosphate mannosyltransferase 1, catalytic subunit | 20q13.13 | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan - CDG1E (2.41)
|
DPM2Dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit | 9q34.13 | * Muscle dystrophy with congenital disorder of glycosylation - (2.43) * Congenital muscular dystrophy and abnormal glycosylation of dystroglycan with se - (2.43)
|
DPM3Dolichyl-phosphate mannosyltransferase polypeptide 3 | 1q22 | * Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B15 - MDDGB15 (1.56, 2.39) * Muscle dystrophy with congenital disorder of glycosylation, type Io - CDG1O (1.56, 2.39)
|
DRP2Dystrophin-related protein 2 | Xq22.1 | * Charcot-Marie-Tooth disease, X-linked recessive related to DRP2 - (14.49)
|
| 18q12.1 | * Arrhythmogenic right ventricular dysplasia, 11 - ARVD11 (10.124)
|
| 18q12.1 | * Arrhythmogenic right ventricular dysplasia, 10 - ARVD10 (10.123, 10.66) * Dilated cardiomyopathy, related to DSG2 - CMD1BB (10.123, 10.66)
|
| 6p24.3 | * Arrhythmogenic right ventricular dysplasia, 8 - ARVD8 (10.121)
|
| 6p12.1 | * Hereditary sensory and autonomic neuropathy type VI - HSAN6 (14.115)
|
| 18q12 | * LGMD related to DTNA - (1.61, 10.104)
|
| 4q35 | * Muscular dystrophy, facioscapulohumeral, type 1A - FSHD1A (1.10)
|
DYNC1H1Dynein, cytoplasmic 1, heavy chain 1 | 14q32.31 | * Charcot-Marie-Tooth disease, axonal, type 20 - CMT2O (12.40, 14.67) * Spinal muscular atrophy, lower extremity, autosomal dominant - SMALED (12.40, 14.67)
|
| 2p12-14 | * Miyoshi myopathy - MM (1.26, 4.1) * Muscular dystrophy, limb-girdle, type 2B - LGMD2B (1.26, 4.1)
|